President Trump could have walked softly and carried a big stick. As pharmaceutical investors see it, he instead stomped ...

President Trump’s executive order to lower drug prices through cross-agency action left pharma leaders scrambling to make ...

The company had also said last month that Paul Stoffels, a pharma legend who took on the CEO role in 2022 in a bid to ...

UnitedHealth said Tuesday its CEO Andrew Witty had stepped down, as the company also suspended its 2025 outlook ...

That’s about how many children in the U.S. live in a household with at least one parent with a substance use disorder, ...

The lines between fact, science, and uncertainty are increasingly blurred. Things once treated as dogma are being questioned.

Biotech investment firm RA Capital has laid off staff at its internal startup incubator, highlighting the instability among ...

Our most dangerous epidemic right now is not Covid, it is obesity, and we have the basic tools to fight it. Means is a ...

Trump's executive order lacks specifics and raises questions on what can be accomplished, what will be challenged in court.

A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...

The emergence of Haemanthus, a company formed by Elizabeth Holmes’ partner, Billy Evans, triggered a mix of shock, anger, and ...

President Trump unveiled his plan to dramatically overhaul the way the U.S. pays for drugs. Pharma investors didn't seem to ...